Go Deep
DexCom, Inc.
DexCom, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 14,583 | 33.4 | 12.11 | 0.53 | 8,122.35 |
| Oct 2026 | 14,352 | 34.1 | 12.37 | 0.53 | 8,226.03 |
| Oct 2026 | 14,728 | 33.8 | 12.24 | 0.53 | 8,100.58 |
| Oct 2026 | 14,928 | 33.1 | 12.02 | 0.53 | 7,925.27 |
| Oct 2026 | 14,392 | 35.5 | 12.63 | 0.53 | 8,329.03 |
| Oct 2026 | 14,604 | 34.1 | 12.39 | 0.53 | 8,149.27 |
| Oct 2026 | 14,611 | 34.1 | 12.38 | 0.53 | 8,152.31 |
| Oct 2026 | 14,642 | 34.0 | 12.34 | 0.53 | 8,129.56 |
| Oct 2026 | 15,334 | 31.8 | 11.55 | 0.53 | 7,591.17 |
| Oct 2026 | 15,579 | 31.1 | 11.27 | 0.53 | 7,392.69 |
| Oct 2026 | 15,627 | 30.9 | 11.22 | 0.53 | 7,387.32 |
DexCom, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,308,400,000.0 | 1,191,900,000.0 | 1,259,600,000.0 | 1,209,300,000.0 |
| Net Profit | 249,100,000.0 | 199,500,000.0 | 267,300,000.0 | 283,800,000.0 |
| EPS | 0.7 | 0.5 | 0.7 | 0.7 |
DexCom, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 4,662,000,000.0 | 4,033,000,000.0 | 3,622,300,000.0 | 2,909,800,000.0 | — |
| Net Profit | 836,300,000.0 | 576,200,000.0 | 541,500,000.0 | 341,200,000.0 | — |
| EPS | 2.1 | 1.5 | 1.4 | 0.9 | — |
DexCom, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 6,339,900,000.0 | 6,484,500,000.0 | 6,264,500,000.0 | 5,391,700,000.0 | — |
| Total Liabilities | 3,593,900,000.0 | 4,381,900,000.0 | 4,195,900,000.0 | 3,259,900,000.0 | — |
| Total Equity | 2,746,000,000.0 | 2,102,600,000.0 | 2,068,600,000.0 | 2,131,800,000.0 | — |
Owes vs Owns
DexCom, Inc. owed $0.59 for every $1 it owned in Jun 2026, down from $0.60 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.59× | 0.57× | 0.68× | 0.67× | 0.60× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
DexCom, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 31.5%Receivables 20.3%Inventory 9.9%Fixed assets (tangible) 25.8%Intangible assets 1.5%Long-term investments 3.4%Other assets 7.4%
How it's funded — Dec 2025
Long-term debt 19.6%Payables 5.4%Other liabilities 31.3%Shareholders' equity 43.3%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,998.7 | 2,579.4 | 2,724.1 | 2,456.2 |
| Receivables | 1,289.9 | 1,044.2 | 987.5 | 752.2 |
| Inventory | 629.1 | 542.6 | 559.6 | 306.7 |
| Fixed assets (tangible) | 1,637.3 | 1,402.7 | 1,184.5 | 1,135.6 |
| Intangible assets | 95.0 | 126.2 | 159.7 | 199.0 |
| Long-term investments | 218.0 | 119.3 | 38.5 | 19.0 |
| Other assets | 471.9 | 670.1 | 610.6 | 523.0 |
| Liabilities & equity | ||||
| Short-term debt | 21.6 | 1,204.4 | 21.1 | 772.6 |
| Long-term debt | 1,240.9 | 1,237.0 | 2,434.2 | 1,197.7 |
| Payables | 344.3 | 345.3 | 276.4 | 237.9 |
| Other liabilities | 1,987.1 | 1,595.2 | 1,464.2 | 1,051.7 |
| Shareholders' equity | 2,746.0 | 2,102.6 | 2,068.6 | 2,131.8 |
| Net tangible assets | 2,651.0 | 1,976.4 | 1,908.9 | 1,932.8 |
DexCom, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 1,440,700,000.0 | 989,500,000.0 | 748,500,000.0 | 669,500,000.0 | — |
| Investing Activities | 536,000,000.0 | -207,500,000.0 | -507,200,000.0 | -521,500,000.0 | — |
| Financing Activities | -1,686,400,000.0 | -734,800,000.0 | -318,600,000.0 | -552,500,000.0 | — |